Epidural Continuous Infusion Inserted Into T2 Using Fluoroscopic Guidance Cpt Code

From 2017, we have many CPT codes replaced for spinal injection procedures. There are many changes in procedure codes from 2017. The list of  CPT codes added for pain management for spinal exams were bundled and very helpful for coders. We will check out CPT code 62320, 62321, 62322, 62323, 62324, 62325, 62326 and 62327 and learn when to use them in place of old deleted codes.

The old deleted codes are the epidural steroid injection CPT codes 62310 and 62311. Also, along with them two more CPT codes are deleted 62318 and 62319. So, let us checkout one by one the new CPT codes for each one of them.

There are may similar injection procedures like arthrocentesis, arthrogram, ,myelogram etc which required guidance codes. We do not have any changes for these exams but if you know them you can easily code these spinal injection procedures. Once, you get perfect in coding surgery procedure, you will surely improve you coding skills in coding.

However, you may be interested in other posts in the series:

When to use CPT code 36901 for AV fistula Access

Superb guide for Certified Coding Specialist or CCS exam

Selective and Non-Selective Catheterization Coding Rules

ICD 10 coding tips for Subsequent encounter in fracture coding

Learn when to use Z codes in ICD 10

Use of CPT code 62320 and 62321

The  CPT code 62320, will be used in place of CPT code 62310. The old CPT code 62310 will be deleted from 2017. Also, we have another new CPT code 62321 for procedures which are done with guidance like CT (Computed tomography) or Fluoroscopy. The guidance code 77003 or 77012 will remain included in the procedure codes, but we have a separate CPT code 62320 for without guidance exam. Let us first checkout the old deleted CPT code first.

Deleted

62310 – Injection(s), of diagnostic or therapeutic substance(s) (including anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, including needle or catheter placement, includes contrast for localization when performed, epidural or subarachnoid; cervical or thoracic

Read also: When to use Fluoroscopy CPT codes in Interventional Radiology

Description of pain management CPT code 62320 and 62321

CPT code 62320 – (Injection[s], of diagnostic or therapeutic substance[s] [eg, anesthetic, antispasmodic, opioid, steroid, other solution], not including neurolytic substances, including needle or catheter placement, interlaminar epidural or subarachnoid, cervical or thoracic; without imaging guidance).

CPT code 62321 – ; with imaging guidance (ie, fluoroscopy or CT)

The coding of these pain management procedures has become easy. Now, the codes also include the guidance codes. Similar changes happened with breast biopsy earlier where they included guidance coded with the breast biopsy codes. These kind of codes reduces the stress of medical coders.

When to use CPT code 62322 and 62323

Here, also we have to follow the same procedure. The deleted CPT code 62311, will have two option in 2017. The new CPT code 62322 and 62323 will be coded depending on the epidural injection and with or without guidance like Fluoroscopy and CT. Below is the deleted CPT code from 2017

Deleted

62311- Injection(s), of diagnostic or therapeutic substance(s) (including anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, including needle or catheter placement, includes contrast for localization when performed, epidural or subarachnoid; lumbar or sacral (caudal)

Read also: When to code Bone Scan CPT codes in Radiology facility

Description of epidural injection CPT code 62322 and 62323 in 2017

CPT code 62322 (Injection[s], of diagnostic or therapeutic substance[s] [eg, anesthetic, antispasmodic, opioid, steroid, other solution], not including neurolytic substances, including needle or catheter placement, interlaminar epidural or subarachnoid, lumbar or sacral [caudal]; without imaging guidance).

CPT code 62323 – ; with imaging guidance (ie, fluoroscopy or CT)

It is very important now to remain updated with the new procedure codes. If you are preparing for medical coding certification exam like CPC, you have to know the coding guidelines for each and every code. Clearing CPC exam in first attempt (out of two attempts) needs lot of hard and smart work. For CCS exam medical coders have only one attempt, hence their is no chance in this to do any mistake. If you fail in first attempt in CPC, you have one more FREE attempt to clear the exam, but if for CCS exam you have first or last attempt only to clear the exam. Try to prepare by solving model CPC or CCS exam paper to know the paper pattern and manage the time.

When to use CPT code 62324 and 62325

Here, also the old CPT code 62318 have been replaced with two new CPT codes 62324 and 62325. You have to again look for the use of guidance like fluoroscopy and CT, to choose the appropriate code.

Deleted in 2017

62318 – Injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance(s) (including anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, includes contrast for localization when performed, epidural or subarachnoid; cervical or thoracic

 CPT code 62324 and 62325 in 2017

CPT code 62324 (Injection[s], including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance[s] [eg, anesthetic, antispasmodic, opioid, steroid, other solution], not including neurolytic substances, interlaminar epidural or subarachnoid, cervical or thoracic; without imaging guidance).

CPT code 62325 – Injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, including needle or catheter placement, interlaminar epidural or subarachnoid, lumbar or sacral (caudal); with imaging guidance (ie, fluoroscopy or CT)

Read also: When to use ICD 10 Z codes as Secondary Diagnosis

When to use CPT code 62326 and 62327

Same guideline is followed for coding the old CPT code 62319. We have two new CPT codes 62326 and 62327 in 2017 to replace the old code 62319. Do check the presence of imaging guidance like fluoroscopy and CT, before coding the CPT code 62326 and 62327 for this exam.

Deleted

62319 – Injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance(s) (including anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, includes contrast for localization when performed, epidural or subarachnoid; lumbar or sacral (caudal)

CPT code 62326 and 62327

CPT code 62326 (Injection[s], including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance[s] [eg, anesthetic, antispasmodic, opioid, steroid, other solution], not including neurolytic substances, interlaminar epidural or subarachnoid, lumbar or sacral [caudal]; without imaging guidance).

CPT code 62327 – Injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, interlaminar epidural or subarachnoid, lumbar or sacral (caudal); with imaging guidance (ie, fluoroscopy or CT)

Read also: How to get Free CEUs for AAPC for Medical coders

When to use  CPT code 62380

There is one more new CPT code for decompression procedure of spines. Earlier, the old code 62287 was use for these exam but in 2017, we have a new CPT code 62380 to code such exam. Hence do use the new CPT code 62380 in place of the old CPT code 62287 from 2017.

Deleted

CPT code 62287 -(Decompression procedure, percutaneous, of nucleus pulposus of intervertebral disc, any method utilizing needle based technique to remove disc material under fluoroscopic imaging or other form of indirect visualization, with the use of an endoscope, with discography and/or epidural injection[s] at the treated level[s], when performed, single or multiple levels, lumbar)

CPT code 62380

62380 – Endoscopic decompression of spinal cord, nerve root(s), including laminotomy, partial facetectomy, foraminotomy, discectomy and/or excision of herniated intervertebral disc, 1 interspace, lumbar

Read also: Difference between aftercare and followup ICD 10 codes

Other related CPT codes for pain management in Surgery

Facet joint injection procedures

64490 Intraarticular joint or medial branch block (MBB) – cervical or thoracic (1st level)

64491 Intraarticular joint or medial branch block (MBB) – cervical or thoracic (2nd level)

64492 Intraarticular joint or medial branch block (MBB) – cervical or thoracic (3rd level)

64493 Intraarticular joint or medial branch block (MBB) – lumbar or sacral (1st level)

64494 Intraarticular joint or medial branch block (MBB) – lumbar or sacral (2nd level)

64495 Intraarticular joint or medial branch block (MBB) – lumbar or sacral (3rd level)

Transforaminal injections Procedures

• 64479, single-level injection cervical/thoracic region;

• 64480, each additional level cervical/thoracic region;

• 64483, single-level injection lumbar/sacral region; and

• 64484, each additional level lumbar/sacral region.

Destruction by Neurolytic Agent (Radiofrequency (RF) ablation procedures)

64626, single level of cervical /thoracic region;

64627, each additional level of cervical /thoracic region;

64622, single level of lumbar/sacral region; and

64623, each additional level of lumbar/sacral region

Coverage Indications, Limitations, and/or Medical Necessity

The epidural space lies outside the dural membrane but inside the spinal canal. It runs the length of the spine and, in addition to traversing nerves, contains fatty tissue and blood vessels. The spinal nerve roots can be affected by a number of processes as they travel through the epidural space, including but not limited to compression from herniation of the nucleus pulposus of the intervertebral discs, degenerative changes involving combinations of the spinal ligaments, discs, zygapophyseal (facet) joints, intraspinal synovial cysts, osteophytes, and mechanical derangements of the spine such as spondylolisthesis. As a result of mechanical irritation, inflammation, injury to a spinal nerve root or other processes, the spinal nerve roots can become a significant and disabling source of radicular pain.

The procedures typically involve the injection of a solution containing anti-inflammatory agents or corticosteroids and anesthetic into the epidural space, although saline may be included at times. The treatment of individuals with spinal disorders, including pain, can be complex, and it is recommended that all individuals being considered for interventional spinal care undergo a thorough evaluation and be treated following development of a comprehensive care plan.

Pain is subjective and consequently difficult to describe accurately and consistently; therefore, the following measures will be used for the purposes of this policy when addressing pain levels or functional capacity. Current tools commonly used to evaluate pain include the Numeric Pain Rating Scale (NPRS) and the Visual Analog Scale (VAS). The following pain level determinations will be used in this policy:

• for the NPRS: a pain rating of less than 3 represents a pain level of none/minimal while a NPRS pain rating of greater than or equal to 3 represents a pain level of moderate or severe/significant.
• pain levels for VAS may be described as none/minimal, or moderate, or severe/significant.

A favorable response to treatment using NPRS is a pain level less than 3. A favorable response using the VAS is obtaining moderate or significant relief.

Sometimes pain levels may be assigned a percentage value or described secondarily as a decreased functional capacity to perform activities of daily living (ADLs). Often a systematic functional screen differentiates normal aging changes from physical diagnoses. For the purposes of this policy, a functional deficit is documented positive findings from a review of key components which may include, but is not limited to, sensory status, mobility/function, or incontinence/elimination issues. These may be recorded using measures such as a Functional Self-Assessment Scale, an Oswestry Disability Index or other similar evaluation tools. Pain relief or pain reduction or a functional ADL performance improvement of greater than or equal to 50% is considered a favorable response to treatment.

Diagnostic injections are used to evaluate a patient's potential benefit from an epidural injection (EI) for treatment of radicular pain and may be used in planning and decision making. Transforaminal epidural injections of local anesthetic agent only are used diagnostically and allow relief benefit for the duration of the effect of the agent.

Epidural injections (EIs) have been shown to reduce radicular pain, and their use may have the effect of lowering surgical rates for specific spinal disorders. The effect of these injections on pain is not curative, but palliative and repeat injections may be beneficial in the management of patients who have a favorable response to an initial injection. The data supporting the use of EIs in the treatment of axial low back pain without radicular origin does not strongly support their use in these circumstances and should not be considered part of routine management of non-specific axial low back pain.

The use of imaging guidance, particularly fluoroscopy or CT, with the use of injectable radio-opaque contrast material has been shown to enhance the accuracy and safety of needle placement for all epidural spinal injection procedures. Sufficient contrast medium should be used to allow for identification of proper injectate flow and to exclude vascular, subarachnoid or subdural flow. There are circumstances, however, where the use of imaging guidance with contrast media is contraindicated.

As with other medical procedures, there are specific risks associated with the performance of EIs, both arising from the procedures themselves as well as the injected agents. These risks include, but are not limited to, the potential for:

• allergic reactions
• intravascular placement with complications that can include neurologic injury
• violation of the dural membrane with the potential for leaks of cerebrospinal fluid (CSF) and further neurological injury from the effects of CSF loss
• infection
• systemic reactions or side effects resulting from the systemic biological effects of corticosteroids

When considering the presence of these risks with the potential for benefit, both patient selection and appropriate image guidance/contrast verification is of paramount importance in order to minimize risks while treating those individuals for whom the injections offer significant benefit. These factors are reflected in the coverage indications that follow.

Covered Indications

Epidural Injections are generally performed to treat pain arising from spinal nerve roots. EIs can be performed via an interlaminar or caudal approach or a transforaminal approach.

An epidural injection is considered reasonable and necessary with the following conditions:

Each patient must be thoroughly evaluated by a physician or non-physician practitioner whose license and state scope of practice allow evaluation and treatment outlined in this LCD. A central or systemic source of pain or neurologic deficit shall be determined prior to epidural injection. If a central or systemic process is present, but the pain or neurologic deficit is clearly unrelated, injection therapy or EI may still be indicated when at least one of the indications listed below is present.

1. Pain from Herpes Zoster or suspected radicular pain based on radiation of pain along the dermatome of a nerve.
2. Pain from Neurogenic claudication that includes any of the following:
   • Pain severe enough to cause some degree of functional deficit;
   • Failure of at least four weeks of noninvasive care*;
   • Imaging demonstrating a correlative region of nerve/cord impingement.
3. Pain from CervicoThoracic or Lumbar radicular pain with any of the following:
   • Pain severe enough to cause some degree of functional deficit;
   • Failure of at least four weeks of non-invasive care*;
   • Imaging demonstrating a correlative region of nerve impingement.
4. Back pain without lower extremities symptoms and failure of four weeks of non-surgical, non-injection care* with either:
   • documented VAS for pain or NPRS greater than or equal to 3/10 (moderate to severe pain), OR
   • functional impairment in ADLs;
     AND
     the pain or functional impairment is associated with any of the following:
   • • substantial imaging abnormality, such as a central disc herniation or high intensity zone;
     • documented severe degenerative disc disease or central spinal stenosis;
     • discogenic pain, not attributable to facet joint or sacroiliac joint pain.

*It is generally accepted that the majority of back radicular pain will improve with conservative treatment over a four week period. All appropriate non-surgical, non-injection treatments which includes appropriate oral medications and physical therapy (to the extent tolerated) should be considered along with a rationale for interventional treatment. Exceptions to the four week non-surgical/non-injection care prior to initiation of epidural injection therapy, should be documented. These may include, but are not limited to one or more of the following:

• • Pain from Herpes Zoster;
  • Severe pain unresponsive to outpatient medical management;
  • Inability to tolerate non-surgical, non-injection care due to co-existing medical conditions(s);
  • At least moderate pain with significant functional loss at work or home;
  • Prior successful lumbar ESI for same specific condition.

Procedural Requirements

1. An appropriately comprehensive documented evaluation of all potential contributing pain generators and treatment in accordance with an established and documented treatment plan.
2. Plain films may be appropriate as a basic requirement to rule out red flag conditions if potential issues of trauma, osteomyelitis or malignancy are a concern.
3. The standard of care for all elective (non-emergent) Epidural Injections includes image-guidance. Fluoroscopy and CT are the only two validated imaging methods considered reasonable and necessary for EIs when using imaging guidance.
4. When imaging guidance is utilized, contrast medium should be injected during epidural injection procedures unless a patient has a contraindication to the injection such as a significant history or a high risk for an adverse event if contrast material is used, e.g. contrast or iodine allergy. In these cases, it is recommended that physicians or non-physician practitioners:
   • consider using a test-dose injection prior to injecting any particulate steroids and/or use only non-particulate solutions, and
   • for cases where it is contraindicated, document in the procedure report the reasons for not using contrast.
5. Diagnostic selective nerve root blocks (DSNRB) with anesthetic only, performed in a manner similar to transforaminal EIs, may be considered in order to further evaluate the anatomical level of radicular pain. If a diagnostic transforaminal injection is planned then baseline (pre-injection) identification of the patient's index pain, intensity of pain (via a visual analog scale or numeric pain rating), neurologic deficits (if they exist) and provocation maneuvers that exacerbate the patient's index pain should be performed.
6. When a diagnostic epidural injection is performed, post treatment assessment of percentage pain relief, NPRS or functional improvement must be performed and documented in the medical record.
7. According to presently accepted standards of care, for each session, injection totals of no more than 80 mg of triamcinolone, or 80 mg of methylprednisolone, or 12 mg of betamethasone, or 15 mg of dexamethasone or equivalent corticosteroid dosing should be administered. Consideration should be given to particulate free steroids such as dexamethasone as first line steroid for EIs.

Additional Suggested Procedural Requirements/Considerations

1. Advanced imaging may be appropriate prior to performing an EI to rule out or establish conditions that would contraindicate or limit effectiveness of injection therapy.
2. Methods to reduce risk of inadvertent vascular injection of particulate steroids with subsequent spinal cord ischemia during performance of transforaminal EIs should be understood and are strongly encouraged. At a minimum, this entails the use of live fluoroscopy with injection of contrast medium to identify any evidence of central vascular uptake. If available, digital subtraction angiography may improve the practitioner's ability to recognize inadvertent vascular uptake. It is standard of care that active agents (e.g., anesthetic and/or corticosteroid) are not injected when central vascular uptake is involved. Safety is enhanced, at the L3 level and above, when only non-particulate corticosteroids are injected when performing transforaminal injections.

Limitations

The following Epidural Injections, regardless of approach or indication, are considered not reasonable and necessary and therefore will be denied:

1. Interlaminar and transforaminal epidural injections using ultrasound guidance are not recommended and are non-covered.
2. For a patient with back pain only, the radiologic findings of a simple disc bulge without correlating symptoms is insufficient to justify performance of an epidural diagnostic or therapeutic injection.
3. Injections are performed independently based on the patient's symptoms and response to prior injections and approach (if performed). There is no role for a routine "series of 3" or undocumented response "test dosing." Repeat or serial test or diagnostic injections without documented response are not considered reasonable and necessary. Response to each epidural injection should be determined prior to determining the value of a repeat injection and the specific methods used for subsequent epidurals.
4. If a prior epidural injection procedure provided limited or no relief (i.e., NPRS less than 3, less than 50% symptom improvement, insignificant or indiscernible relief), a second epidural injection utilizing the same method, technique or medication to the same level will be considered not medically reasonable and necessary. A second injection involving a change in technique or medication will be considered following re-evaluation of the patient. If a patient does not obtain significant relief with a diagnostic selective nerve root block (DSNRB), therapeutic injections (EI) in that same area will be considered not medically necessary.
5. For caudal or interlaminar injections, only one level may be performed, and NOT in conjunction with transforaminal injection in the same region. Caudal or interlaminar injection is not considered medically reasonable and necessary in conjunction with transforaminal injections at the same session, for the same level, or within three contiguous levels of the same region (lumbosacral or cervicothoracic).
6. It should not be necessary to perform both transforaminal epidural and paravertebral facet joint injections at the same spinal level at the same encounter, unless a synovial cyst is compressing the nerve root. In this situation, EI may provide relief for the radicular pain while the cyst rupture allows nerve root decompression. It is not expected that additional injection whether EI or Paravertebral Facet Joint at a different level would be performed on the same day. When a facet joint injection and an epidural injection are performed for the purpose of rupturing a cyst, the facet joint injection counts as one of the two injections allowed on the same day. For additional information on facet joint injections please refer to JL LCD L34892, Paravertebral Facet and Sacroiliac Joint Injections or JH LCD L34974, Facet Joint Injections.
7. If the muscles surrounding the lumbar joint are injected in lieu of the epidural space, an epidural injection should not be reported as this would not support the service. A transforaminal injection without documentation of imaging will be considered not medically reasonable and necessary. Please refer to LCD L35010, Trigger Point Injections, for additional information.
8. It is considered not reasonable and necessary to perform more than 2 epidural injections in a single setting (e.g., single level bilaterally or two levels unilaterally).
   Levels per session:

• No more than two epidural injections (CPT codes 64479, 64480, 64483, or 64484) may be performed at a single session (i.e., single level bilaterally or two levels unilaterally).
• One caudal or interlaminar injection (CPT codes 62320, 62321, 62322, 62323, 62324, 62325, 62326, 62327), not in conjunction with a transforaminal injection (CPT codes 64479, 64480, 64483, or 64484) of the same region, may be performed per session.

• For each session, doses less than or equal to 80 mg of triamcinolone, or 80 mg of methylprednisolone, or 12 mg of betamethasone, or 15 mg of dexamethasone or equivalent corticosteroid are considered standard of care. Administration of dosing greater than these levels is considered not medically reasonable and necessary.

Contraindications to Epidural Injection or Diagnostic Selective Nerve Root Block

1. Cancer
   • Medicare considers it not appropriate, as there would be no expected benefit, to perform an EI for a beneficiary with cancer where the tumor is invading a nerve root.
   • Epidural injection of local anesthetic or anti-inflammatory agents is not appropriate for the management of non-lateralizing, non-specific pain or discomfort not related to inflammation, compression, or injury to spinal nerve roots or their extensions. It is considered not appropriate to perform EIs in the following situations (this list is not all inclusive):
     • For patients with lung cancer irritating the pleura.
     • For patients with large abdominal or pancreatic tumors.
     • For cancer patients with generalized lateral pain.
     • For pain due to metastatic disease.
2. Infection
   • New onset of neck or back pain with fever in the absence of advanced imaging studies (to rule out local infection).
   • Risk factors for spinal infection including fever or history of intravenous drug use.
   • History of recent or ongoing bacterial or fungal infection.
   • Immunosuppression.
3. Cauda Equina Syndrome
   • New onset of urinary retention, fecal incontinence or saddle anesthesia.
   • Rapidly progressing (or other) neurologic deficits.
4. A medical condition that contraindicates the intervention, (e.g., epidural hematoma, subarachnoid hemorrhage, epidural mass, spinal cord ischemia, trauma).
5. A co-existing medical condition or therapy that precludes the safe performance of the procedure (e.g., uncontrolled coagulopathy or active anti-coagulation therapy, sepsis).
6. The potential presence of a Central Nervous System process resulting in the presenting symptoms, (e.g., transverse myelitis, central demyelination) suggested by numbness or weakness without paresthesia/dysesthesia or pain.

Anesthesia

Standard medical practice utilizes local anesthesia for epidural injection procedures.

Occasionally, minimal to moderate conscious sedation for epidural injections may be appropriate.

Use of General Anesthesia (GA), Moderate Sedation and Monitored Anesthesia Care (MAC) is usually unnecessary or rarely required for these injections. Documentation must clearly establish the need for such sedation in the specific patient. Please refer to LCD L35049, Monitored Anesthesia Care, for information related to MAC.

Bill Type Codes:

Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the policy does not apply to that Bill Type. Complete absence of all Bill Types indicates that coverage is not influenced by Bill Type and the policy should be assumed to apply equally to all claims.

012x	Hospital Inpatient (Medicare Part B only)
013x	Hospital Outpatient
083x	Ambulatory Surgery Center
085x	Critical Access Hospital

Revenue Codes:

Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory. Unless specified in the policy, services reported under other Revenue Codes are equally subject to this coverage determination. Complete absence of all Revenue Codes indicates that coverage is not influenced by Revenue Code and the policy should be assumed to apply equally to all Revenue Codes.

Note: The contractor has identified the Bill Type and Revenue Codes applicable for use with the CPT/HCPCS codes included in this LCD. Providers are reminded that not all CPT/HCPCS codes listed can be billed with all Bill Type and/or Revenue Codes listed. CPT/HCPCS codes are required to be billed with specific Bill Type and Revenue Codes. Providers are encouraged to refer to the CMS Internet-Only Manual (IOM) Pub. 100-04,Medicare Claims Processing Manual, for further guidance.

032X	Radiology – Diagnostic – General Classification
033X	Radiology – Therapeutic and/or Chemotherapy Administration – General Classification
049X	Ambulatory Surgical Care – General Classification
051X	Clinic – General Classification

ICD-10 Codes that Support Medical Necessity

Medicare is establishing the following limited coverage for CPT/HCPCS codes: 62321, 62323, 62325, 62327, 64479, 64480, 64483, and 64484.

ICD-10 CODE	DESCRIPTION
B02.23	Postherpetic polyneuropathy
B02.7	Disseminated zoster
B02.8	Zoster with other complications
B02.9	Zoster without complications
G54.4	Lumbosacral root disorders, not elsewhere classified
G89.18	Other acute postprocedural pain
G96.12*	Meningeal adhesions (cerebral) (spinal)
G96.19*	Other disorders of meninges, not elsewhere classified
G97.1	Other reaction to spinal and lumbar puncture
M43.12	Spondylolisthesis, cervical region
M43.13	Spondylolisthesis, cervicothoracic region
M43.14	Spondylolisthesis, thoracic region
M43.15	Spondylolisthesis, thoracolumbar region
M43.16	Spondylolisthesis, lumbar region
M43.17	Spondylolisthesis, lumbosacral region
M47.22	Other spondylosis with radiculopathy, cervical region
M47.23	Other spondylosis with radiculopathy, cervicothoracic region
M47.24	Other spondylosis with radiculopathy, thoracic region
M47.25	Other spondylosis with radiculopathy, thoracolumbar region
M47.26	Other spondylosis with radiculopathy, lumbar region
M47.27	Other spondylosis with radiculopathy, lumbosacral region
M47.812	Spondylosis without myelopathy or radiculopathy, cervical region
M47.813	Spondylosis without myelopathy or radiculopathy, cervicothoracic region
M47.814	Spondylosis without myelopathy or radiculopathy, thoracic region
M47.815	Spondylosis without myelopathy or radiculopathy, thoracolumbar region
M47.816	Spondylosis without myelopathy or radiculopathy, lumbar region
M47.817	Spondylosis without myelopathy or radiculopathy, lumbosacral region
M48.02	Spinal stenosis, cervical region
M48.03	Spinal stenosis, cervicothoracic region
M48.04	Spinal stenosis, thoracic region
M48.05	Spinal stenosis, thoracolumbar region
M48.062	Spinal stenosis, lumbar region with neurogenic claudication
M48.07	Spinal stenosis, lumbosacral region
M50.121	Cervical disc disorder at C4-C5 level with radiculopathy
M50.122	Cervical disc disorder at C5-C6 level with radiculopathy
M50.123	Cervical disc disorder at C6-C7 level with radiculopathy
M50.13	Cervical disc disorder with radiculopathy, cervicothoracic region
M51.14	Intervertebral disc disorders with radiculopathy, thoracic region
M51.15	Intervertebral disc disorders with radiculopathy, thoracolumbar region
M51.16	Intervertebral disc disorders with radiculopathy, lumbar region
M51.17	Intervertebral disc disorders with radiculopathy, lumbosacral region
M51.24	Other intervertebral disc displacement, thoracic region
M51.25	Other intervertebral disc displacement, thoracolumbar region
M51.26	Other intervertebral disc displacement, lumbar region
M51.27	Other intervertebral disc displacement, lumbosacral region
M51.34	Other intervertebral disc degeneration, thoracic region
M51.35	Other intervertebral disc degeneration, thoracolumbar region
M51.36	Other intervertebral disc degeneration, lumbar region
M51.37	Other intervertebral disc degeneration, lumbosacral region
M54.12	Radiculopathy, cervical region
M54.13	Radiculopathy, cervicothoracic region
M54.14	Radiculopathy, thoracic region
M54.15	Radiculopathy, thoracolumbar region
M54.16	Radiculopathy, lumbar region
M54.17	Radiculopathy, lumbosacral region
M54.18	Radiculopathy, sacral and sacrococcygeal region
M54.31	Sciatica, right side
M54.32	Sciatica, left side
M96.1	Postlaminectomy syndrome, not elsewhere classified
M99.21	Subluxation stenosis of neural canal of cervical region
M99.22	Subluxation stenosis of neural canal of thoracic region
M99.23	Subluxation stenosis of neural canal of lumbar region
M99.31	Osseous stenosis of neural canal of cervical region
M99.32	Osseous stenosis of neural canal of thoracic region
M99.33	Osseous stenosis of neural canal of lumbar region
M99.41	Connective tissue stenosis of neural canal of cervical region
M99.42	Connective tissue stenosis of neural canal of thoracic region
M99.43	Connective tissue stenosis of neural canal of lumbar region
M99.51	Intervertebral disc stenosis of neural canal of cervical region
M99.52	Intervertebral disc stenosis of neural canal of thoracic region
M99.53	Intervertebral disc stenosis of neural canal of lumbar region
M99.61	Osseous and subluxation stenosis of intervertebral foramina of cervical region
M99.62	Osseous and subluxation stenosis of intervertebral foramina of thoracic region
M99.63	Osseous and subluxation stenosis of intervertebral foramina of lumbar region
M99.71	Connective tissue and disc stenosis of intervertebral foramina of cervical region
M99.72	Connective tissue and disc stenosis of intervertebral foramina of thoracic region
M99.73	Connective tissue and disc stenosis of intervertebral foramina of lumbar region

Note: ICD-10 codes G96.12 and G96.19 are to be used to describe lumbar epidural fibrosis, not otherwise described by ICD-10 codes

References: https://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=36920&ver=32&name=331*1&UpdatePeriod=765&bc=AAAAEAAAAAAA&

mcdowellbellon.blogspot.com

Source: https://www.americanmedicalcoding.com/cpt-code-62320-62322-62324-62326/

Share this post